[6-K] WeRide Inc. American Current Report (Foreign Issuer)

Rhea-AI Filing Summary

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2025

------------

Commission File Number: 001-42213

------------

WeRide Inc.

21st Floor, Tower A, Guanzhou Life Science Innovation Center
No. 51, Luoxuan Road, Guangzhou International Biotech Island
Guangzhou 510005
People's Republic of China
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [ X ]      Form 40-F [   ] 

EXHIBIT INDEX 

99.1 Press Release — WeRide Accelerates Global Growth, Robotaxi Revenue Grew 836.7%; WeRide Announces Unaudited Financial Results for Q2 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	WeRide Inc.
Date: July 31, 2025	By:	/s/ Jennifer Li
	Name:	Jennifer Li
	Title:	Chief Financial Officer